Variant | N (n = 402) |
---|---|
Procedure | |
Left upper lobectomy | 96 (23.9%) |
Left lower lobectomy | 67 (16.7%) |
Right upper lobectomy | 126 (31.3%) |
Right middle lobectomy | 35 (8.7%) |
Right lower lobectomy | 66 (16.4%) |
Right upper and middle lobectomy | 3 (0.7%) |
Right middle and lower lobectomy | 9 (2.3%) |
Pathology | |
Adenocarcinoma | 306 (76.1%) |
Squamous carcinoma | 78 (19.4%) |
Adenosquamous carcinoma | 12 (3.0%) |
Carcinoid | 2 (0.5%) |
Othersa | 4 (1.0%) |
Pathological stage | |
Ia | 115 (28.6%) |
Ib | 207 (51.5%) |
IIa | 31 (7.7%) |
IIIa | 49 (12.2%) |
Complications | |
Pneumonia | 26 (6.5%) |
Air leakage >7 daysb | 12 (3.0%) |
Drainage >7 daysc | 7 (1.7%) |
Arrhythmia | 5 (1.3%) |
Asthma | 3 (0.7%) |
Chylothorax | 3 (0.7%) |
Recurrent laryngeal nerve paralysis | 3 (0.7%) |
Pneumonia + Drainage >7 days | 2 (0.5%) |
Pulmonary embolism | 2 (0.5%) |
Postoperative hemorrhage | 2 (0.5%) |
Othersd | 5 (1.3%) |